{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:53:41Z","timestamp":1793278421174,"version":"4.5.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Early recognition and treatment of heparin-induced thrombocytopenia (HIT) are crucial to prevent severe complications. Although immunoassays offer rapid diagnosis, their sensitivity and specificity are suboptimal. Sequential combinations of quantitative immunoassay results improve their diagnostic accuracy. We aimed to validate 2 Bayesian approaches combining 2 rapid immunoassays and to compare their diagnostic performance with 2 other diagnostic approaches (Hamilton and TORADI-HIT algorithms). We included 1194 patients with suspected HIT, of whom 6.0% had confirmed HIT. HemosIL Acustar HIT-IgG (chemiluminescent immune assay [CLIA]) and HemosIL HIT-Ab (latex immune-turbidimetric assay [LIA]) (Instrumentation Laboratory, Munich, Germany) were performed. Definite HIT confirmation or exclusion was made using heparin-induced platelet activation (HIPA) test and platelet factor 4\u2013enhanced HIPA (PIPA). Our sequential approaches (CLIA first and LIA for 15-20% unsolved cases or vice versa) correctly excluded HIT in 95.6% and 96.4%, predicted HIT in 95.8% and 97.2%, with 3.3% and 2.3% of cases remaining undetermined; there were no false-negative predictions, and 13 and 15 false-positive predictions, respectively The modified version of the Hamilton algorithm correctly excluded HIT in 92.1% and predicted HIT in 97.2% with 88 false-positive and 2 false-negative results. The TORADI-HIT algorithm correctly excluded HIT in 97.9% and predicted HIT in 93.8% (10 false positives, 3 false negatives). In conclusion, a Bayesian approach sequentially using 2 immunoassays is accurate for HIT diagnosis. Performing immunoassays simultaneously without considering clinical pretest probability misses HIT cases. The TORADI-HIT algorithm offers better HIT exclusion with a 6% false-negative rate. Using our Bayesian approach, HIT exclusion or recognition can be achieved in \u226597% of cases within &amp;lt;1 hour.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2024027517","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T16:03:21Z","timestamp":1747929801000},"page":"887-896","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Sequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopenia"],"prefix":"10.1182","volume":"146","author":[{"given":"Thomas","family":"Steinauer","sequence":"first","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"},{"name":"2Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Matthey-Guirao","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2208-2070","authenticated-orcid":false,"given":"Francisco J.","family":"Gomez","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Rittener-Ruff","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7741-0740","authenticated-orcid":false,"given":"Matteo","family":"Marchetti","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Goodyer","sequence":"additional","affiliation":[{"name":"3Division of Hematology and Laboratory of Hematology, Institut Central des H\u00f4pitaux, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Nabergoj","sequence":"additional","affiliation":[{"name":"3Division of Hematology and Laboratory of Hematology, Institut Central des H\u00f4pitaux, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Barelli","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grandoni","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-8268","authenticated-orcid":false,"given":"Maxime G.","family":"Zermatten","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-9920","authenticated-orcid":false,"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"},{"name":"2Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"21","key":"2025081411221073200_bib1","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"issue":"3","key":"2025081411221073200_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Clinical practice: heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"2025081411221073200_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0038-1656329","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral","year":"1992","journal-title":"Thromb Haemost"},{"issue":"20","key":"2025081411221073200_bib4","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2025081411221073200_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pathol.2017.11.089","article-title":"HIT or miss? a comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia","volume":"50","author":"Favaloro","year":"2018","journal-title":"Pathology"},{"issue":"4","key":"2025081411221073200_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1055\/a-1223-3329","article-title":"Challenges in detecting clinically relevant heparin-induced thrombocytopenia antibodies","volume":"40","author":"Warkentin","year":"2020","journal-title":"Hamostaseologie"},{"issue":"2","key":"2025081411221073200_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.seminhematol.2022.03.003","article-title":"Laboratory testing for VITT antibodies","volume":"59","author":"Warkentin","year":"2022","journal-title":"Semin Hematol"},{"issue":"5","key":"2025081411221073200_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2015-07-661215","article-title":"Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"127","author":"Nagler","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2025081411221073200_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MOH.0b013e32830b84a2","article-title":"Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment","volume":"15","author":"Alberio","year":"2008","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 1","key":"2025081411221073200_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1538-7836.2011.04322.x","article-title":"HIT paradigms and paradoxes","volume":"9","author":"Warkentin","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2025081411221073200_bib11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1160\/TH15-06-0523","article-title":"Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"115","author":"Sun","year":"2016","journal-title":"Thromb Haemost"},{"issue":"2","key":"2025081411221073200_bib12","first-page":"402","article-title":"Evaluation of a new automated panel of assays for the detection of anti-PF4\/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia","volume":"104","author":"Legnani","year":"2010","journal-title":"Thromb Haemost"},{"key":"2025081411221073200_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.thromres.2017.03.010","article-title":"Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL(\u00ae) HIT-Ab((PF4-H))] for the diagnosis of immune heparin-induced thrombocytopenia","volume":"153","author":"Warkentin","year":"2017","journal-title":"Thromb Res"},{"issue":"6","key":"2025081411221073200_bib14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1160\/TH11-06-0390","article-title":"Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT)","volume":"106","author":"Sachs","year":"2011","journal-title":"Thromb Haemost"},{"issue":"9189","key":"2025081411221073200_bib15","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(99)03625-9","article-title":"Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4)","volume":"354","author":"Meyer","year":"1999","journal-title":"Lancet"},{"issue":"22","key":"2025081411221073200_bib16","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"14","key":"2025081411221073200_bib17","first-page":"1171","article-title":"Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia","volume":"135","author":"Marchetti","year":"2020","journal-title":"Blood"},{"issue":"14","key":"2025081411221073200_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2019004676","article-title":"Diagnosing HIT: the need for speed","volume":"135","author":"Cuker","year":"2020","journal-title":"Blood"},{"issue":"Suppl 1","key":"2025081411221073200_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ijlh.13564","article-title":"Diagnosing heparin-induced thrombocytopenia: the need for accuracy and speed","volume":"43","author":"Pishko","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"10","key":"2025081411221073200_bib20","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/jth.15811","article-title":"Combinations of rapid immunoassays for a speedy diagnosis of heparin-induced thrombocytopenia","volume":"20","author":"Rittener-Ruff","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2025081411221073200_bib21","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/jth.14794","article-title":"Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT)","volume":"18","author":"Warkentin","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2025081411221073200_bib22","doi-asserted-by":"crossref","first-page":"101745","DOI":"10.1016\/j.eclinm.2022.101745","article-title":"A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: a prospective, multicenter, observational study","volume":"55","author":"Nilius","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"8","key":"2025081411221073200_bib23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1055\/s-0044-1786749","article-title":"Evaluating diagnostic algorithms for heparin-induced thrombocytopenia using two combined automated rapid immunoassays","volume":"50","author":"Bissola","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"2025081411221073200_bib24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2141.2005.05381.x","article-title":"Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies","volume":"128","author":"Pouplard","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"2025081411221073200_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2025081411221073200_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1538-7836.2011.04552.x","article-title":"Prospective evaluation of the interobserver reliability of the 4Ts score in patients with suspected heparin-induced thrombocytopenia","volume":"10","author":"Nagler","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"2025081411221073200_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ijlh.14261","article-title":"A career in solving clinical-pathological conundrums: Heyde syndrome, anti-platelet factor 4 disorders, and microvascular limb ischemic necrosis","volume":"46","author":"Warkentin","year":"2024","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"2025081411221073200_bib28","first-page":"439","article-title":"Heparin-induced thrombocytopenia: a clinicopathologic syndrome","volume":"82","author":"Warkentin","year":"1999","journal-title":"Thromb Haemost"},{"issue":"1","key":"2025081411221073200_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3324\/haematol.2011.048074","article-title":"Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients","volume":"97","author":"Nellen","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"2025081411221073200_bib30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","article-title":"Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia","volume":"106","author":"Wallis","year":"1999","journal-title":"Am J Med"},{"issue":"5","key":"2025081411221073200_bib31","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/jth.15262","article-title":"COVID-19 patients often show high-titer non-platelet-activating anti-PF4\/heparin IgG antibodies","volume":"19","author":"Brodard","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2025081411221073200_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ajh.24979","article-title":"Laboratory tests for identification or exclusion of heparin induced thrombocytopenia: HIT or miss?","volume":"93","author":"Favaloro","year":"2018","journal-title":"Am J Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/7\/887\/2405847\/blood_bld-2024-027517-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/7\/887\/2405847\/blood_bld-2024-027517-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T15:22:22Z","timestamp":1755184942000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/7\/887\/537387\/Sequential-combinations-of-rapid-immunoassays-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024027517","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,14]]},"published":{"date-parts":[[2025,8,14]]}}}